Drug Costs – Talk Bio

Actionable Insights Powered by AI

Trump Taps Dr. Oz as Lead Negotiator for ‘Most Favored Nation’ Drug Pricing Policy

2 weeks ago talkbio0Tagged Dr., Drug Costs, drug price, Health Policy, Myasthenic Syndromes, Congenital, Nation, ounce, pharmaceutical negotiations, Transplant Registry Unified Management Program

Trump; Dr. Mehmet Oz; Most Favored Nation; drug pricing; CMS; pharmaceutical negotiations; healthcare policy; drug costs

Senators Wyden and Brown Call for FTC Investigation into PBM “Co-Manufacturing” Practices

8 months ago talkbio0Tagged Benefit, Co-Manufacturing, competition, Drug Costs, Evaluation, Healthcare Industry, manager, Pharmaceutical Services, Pharmacy Benefit Manager, United States Federal Trade Commission

PBM reforms, FTC investigation, co-manufacturing, pharmacy benefit managers, drug costs, competition, healthcare industry